Search results
Results from the WOW.Com Content Network
Description: United States Patent 6630507 "Cannabinoids as antioxidants and neuroprotectants" issued to The United States of America as represented by the Department of Health and Human Services
E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...
Drug Price Competition and Patent Term Restoration Act; Long title: An Act to amend the Federal Food, Drug, and Cosmetic Act to revise the procedures for new drug applications, to amend title 35, United States Code, to authorize the extension of the patents for certain regulated products, and for other purposes.
The issue of novelty often arises during patent examination, because of inadvertent and/or partial disclosures by inventors themselves prior to filing a patent application. [citation needed] Unlike the laws of most countries, the US patent law provides for a one-year grace period in cases of inventor's own prior disclosure. [28]
In other words, when an applicant files an application for a patent or a trademark in a foreign country member of the Union, the application receives the same treatment as if it came from a national of this foreign country. Furthermore, if the intellectual property right is granted (e.g. if the applicant becomes owners of a patent or of a ...
In 1945, it was renamed again as Rumah Sakit Umum Pusat (RSUP). In 1964, after Indonesia's independence, the name changed to Rumah Sakit Tijpto Mangunkusumo (RSTM), now RSCM, to match the Indonesian language. In 1994, the hospital was renamed Rumah Sakit Umum Pusat Dr. Cipto Mangunkusumo (RSUP Dr. Cipto Mangunkusumo). In 2008, a new building ...
Patent examiners at the United States Patent and Trademark Office (USPTO) examine patent applications for claims of new inventions. Examiners make determinations of patentability based on policies and guidance from this agency, in compliance with federal laws (Title 35 of the United States Code), rules, judicial precedents, and guidance from agency administrators.
Simple patent family: All patent documents have exactly the same priority date or combination of priority dates. [4] Extended patent family: All patent documents are linked (directly or indirectly) via a priority document belonging to one patent family. The extended families allow for additional connectors to link other than strictly priority date.